Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Published in: European Journal of Nutrition 5/2013

01-08-2013 | Letter to the Editor

Comment on “Nutrient reference values for bioactives: new approaches needed? A conference report” (European Journal of Nutrition, April 2013, Volume 52, Issue 1 Supplement, pp 1–9)

Author: Paula R. Trumbo

Published in: European Journal of Nutrition | Issue 5/2013

Login to get access

Excerpt

I have read this article with much interest and would like to provide some clarification. The abstract of this article notes that the US Food and Drug Administration (FDA) sets a labeling value for dietary fiber based on the Institute of Medicine (IOM) Adequate Intake (AI). In 1993, FDA established a Daily Value for dietary fiber (25 g) based on a report from the Life Sciences Research Office (LSRO) that was published in 1987 [1]. Although the IOM set an AI for dietary fiber in 2002 [2], the current Daily Value for dietary fiber continues to be based on the 1987 LSRO report. …
Literature
1.
Life Sciences Research Office, Federation of American Societies for Experimental Biology (1987) Physiological effects and health consequences of dietary fiber. Bethesda, MD
2.
IOM (2002) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. National Academies Press, Washington, DC
Metadata
Title
Comment on “Nutrient reference values for bioactives: new approaches needed? A conference report” (European Journal of Nutrition, April 2013, Volume 52, Issue 1 Supplement, pp 1–9)
Author
Paula R. Trumbo
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 5/2013
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-013-0537-3

Other articles of this Issue 5/2013

European Journal of Nutrition 5/2013 Go to the issue

Original Contribution

Challenges in estimating the validity of dietary acrylamide measurements

Original Contribution

Confirmatory factor analysis to assess the measure of adiposity that best fits the diagnosis of metabolic syndrome and relationship to physical activity in adults

Reply

Response to Letter to the Editor from Dr. Safer et al. regarding the article “Age-related changes in body composition in a sample of Czech women aged 18–89 years: a cross-sectional study,” published in European Journal of Nutrition

Review

Mechanisms underlying the anti-wasting effect of l-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies

Original Contribution

Riboflavin depletion of intestinal cells in vitro leads to impaired energy generation and enhanced oxidative stress

Original Contribution

Long-term effects of a neonatal low-protein diet in rats on the number of macrophages in culture and the expression/production of fusion proteins
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits